Chronic Hepatitis B treatment
搜索文档
Precision BioSciences, Inc. (DTIL) Discusses ARCUS Platform Progress and ELIMINATE-B Clinical Trial Update for Chronic Hepatitis B Transcript
Seeking Alpha· 2025-11-12 05:11
PresentationIt is now my pleasure to turn the call over to Naresh Tanna, Head of Investor Relations. The floor is yours.Thank you for standing by. My name is Tina, and I will be your conference operator today. At this time, I would like to welcome everyone to the Precision BioSciences AASLD update call. [Operator Instructions]Naresh TannaChief of Staff to CEO & Head of Investor Relations Thank you, Tina. Good morning, everyone, and welcome to the Precision BioSciences 2025 AASLD business update. I am joined ...